Bradycardia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-07-17
Clinical Trial Update: Clinical Evaluation of the Sorin Group's REPLY MR-conditional Pacing System [Phase 3]
Phase 3 trial evaluating the REPLY MR-conditional Pacing System for dual-chamber pacemaker placement has been withdrawn.